The significant reduction in proteinuria (median reduction of 89.2% at week 52) and improvement in serum albumin levels indicate substantial resolution of nephrotic syndrome, a key determinant of long-term renal outcomes in LN. The gene discussed is ALB; the disease is nephrotic syndrome.